Diabetes Mellitus: all 11,090 studies

Page 25 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.

• Model Driven Diabetes CareCompletedNCT01774149Not applicableResults posted
• CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1CompletedNCT01773707Phase 2Results posted
• Comparison of Insulin Mix25 Versus Mix50CompletedNCT01773473Phase 4Results posted
• A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 DiabetesCompletedNCT01771250Phase 1Results posted
• A Study of LY2605541 and Glargine in Participants With Type 1 DiabetesCompletedNCT01769404Phase 1Results posted
• Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)CompletedNCT01769378Phase 3Results posted
• A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031)CompletedNCT01767688Phase 1Results posted
• Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by MetforminCompletedNCT01766778Phase 4Results posted
• Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft SurgeryTerminatedNCT01765270Phase 4Results posted
• A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)CompletedNCT01760447Phase 3Results posted
• A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)CompletedNCT01755156Phase 3Results posted
• NEAT! Technology to Increase Breaks in Sedentary Behavior in Adults With DiabetesCompletedNCT01754467Not applicableResults posted
• Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CADCompletedNCT01754259Phase 3Results posted
• Liraglutide In Overweight Patients With Type 1 DiabetesCompletedNCT01753362Phase 3Results posted
• Lipid Biomarkers for Diabetic Heart DiseaseCompletedNCT01752842Not applicableResults posted
• A Study of LY2922083 in Healthy Participants and Participants With DiabetesCompletedNCT01748552Phase 1Results posted
• A Study of LY2922470 in Healthy Participants and Participants With DiabetesCompletedNCT01746017Phase 1Results posted
• Intervention to Increase Screening for Glucocorticoid Induced DiabetesCompletedNCT01743963Not applicableResults posted
• Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes MellitusCompletedNCT01742208Phase 2Results posted
• Vitamin D for Established Type 2 Diabetes (DDM2)CompletedNCT01736865Phase 2/3Results posted
• Computerized Cognitive Training for Diabetic Elderly VeteransCompletedNCT01736124Phase 4Results posted
• Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 DiabetesCompletedNCT01734785Phase 3Results posted
• A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)CompletedNCT01733758Phase 3Results posted
• Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are ObeseTerminatedNCT01728116Not applicableResults posted
• User Evaluation of the MiniMed 620G and 640G Insulin PumpsCompletedNCT01726621Not applicableResults posted
• Effect of Vitamin D on the Honeymoon Period in Children and Adolescents With Type 1 DiabetesCompletedNCT01724190Not applicableResults posted
• Incentives, Cognitive Training and Internet Therapy for Teens With Poorly Controlled Type 1 DiabetesCompletedNCT01722643Not applicableResults posted
• Liraglutide in the Treatment of Type 1 Diabetes MellitusCompletedNCT01722266Phase 3Results posted
• Liraglutide in Type 1 DiabetesCompletedNCT01722240Phase 3Results posted
• Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 DiabetesCompletedNCT01720446Phase 3Results posted
• Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 DiabetesCompletedNCT01719003Phase 3Results posted
• A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)CompletedNCT01717313Phase 3Results posted
• Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System EfficacyCompletedNCT01714505Not applicableResults posted
• A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime InsulinCompletedNCT01713530Phase 3Results posted
• Sensor and Software Use for Improved Glucose Control in MDI Managed DiabetesCompletedNCT01713348Phase 4Results posted
• A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)CompletedNCT01709305Phase 4Results posted
• Effects of Micronutrient (Chromium) Supplementation on DiabetesCompletedNCT01709123Not applicableResults posted
• A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes MellitusCompletedNCT01707147Results posted
• Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)CompletedNCT01704261Phase 3Results posted
• Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)CompletedNCT01703221Phase 3Results posted
• A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (MK-3102-018)TerminatedNCT01703208Phase 3Results posted
• Point-of-Care Glucose Testing and Insulin SupplementationCompletedNCT01702311Not applicableResults posted
• A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)CompletedNCT01702298Phase 3Results posted
• A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)CompletedNCT01698775Phase 3Results posted
• Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and TitrationCompletedNCT01698528Not applicableResults posted
• Effect of Mobile Phone Telemedicine on Diabetes CareCompletedNCT01698008Not applicableResults posted
• Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)CompletedNCT01697592Phase 3Results posted
• Oral Propionate to Treat and Prevent DiabetesTerminatedNCT01692002Not applicableResults posted
• A Clinical Trial to Prevent New Onset Diabetes After TransplantationCompletedNCT01683331Phase 4Results posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes MellitusCompletedNCT01683266Phase 3Results posted
• A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)CompletedNCT01682759Phase 3Results posted
• Barriers to Adherence to Recommended Follow-up in Women With a History of Gestational DiabetesCompletedNCT01681147Not applicableResults posted
• Testing State of the Art Remote Glucose Monitoring at Diabetes CampCompletedNCT01680653Not applicableResults posted
• Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin GlargineCompletedNCT01680341Phase 3Results posted
• Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume CombinationsCompletedNCT01680328Phase 1Results posted
• A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)TerminatedNCT01678820Phase 3Results posted
• Study of Raisins Versus Alternative Snacks in Patients With Type 2 Diabetes MellitusCompletedNCT01677936Phase 4Results posted
• Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DMCompletedNCT01677299Phase 1/2Results posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic TherapyCompletedNCT01676220Phase 3Results posted
• The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD TherapyCompletedNCT01676116Phase 3Results posted
• A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes MellitusCompletedNCT01673191Phase 2Results posted
• Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes MellitusCompletedNCT01673178Phase 1Results posted
• An Educational Intervention for Type 2 Diabetes PatientsCompletedNCT01671345Not applicableResults posted
• Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 DiabetesCompletedNCT01664624Phase 1Results posted
• The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment IntensificationCompletedNCT01664247Phase 3Results posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime InsulinCompletedNCT01658579Phase 2Results posted
• The Effect of Whole Almonds on Biomarkers of Cardiovascular Disease in Chinese Patients With Type 2 DiabetesCompletedNCT01656850Not applicableResults posted
• A Study of LY2605541 Versus Insulin Glargine on Blood SugarCompletedNCT01654380Phase 1Results posted
• Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 DiabetesCompletedNCT01653210Results posted
• Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes MellitusCompletedNCT01652729Phase 3Results posted
• Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 DiabetesCompletedNCT01652716Phase 3Results posted
• Using Peer Mentors to Support PACT Team Efforts to Improve Diabetes ControlCompletedNCT01651117Not applicableResults posted
• Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes MellitusCompletedNCT01650259Results posted
• A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin TherapyCompletedNCT01649297Phase 2Results posted
• A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes MellitusCompletedNCT01648582Phase 3Results posted
• Fatty Acid Radiotracer Comparison Study in Heart Failure PatientsCompletedNCT01648296Early Phase 1Results posted
• Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 DiabetesTerminatedNCT01647542Phase 3Results posted
• Translating a Heart Disease Lifestyle Intervention Into the CommunityCompletedNCT01647438Not applicableResults posted
• Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 DiabetesCompletedNCT01646320Phase 3Results posted
• A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes MellitusCompletedNCT01644500Phase 3Results posted
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002)CompletedNCT01640873Phase 1Results posted
• Study of LY2409021 in Participants With Type 1 DiabetesCompletedNCT01640834Phase 1Results posted
• Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II DiabetesCompletedNCT01637935Results posted
• Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep ApneaCompletedNCT01629862Phase 2Results posted
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes MellitusCompletedNCT01627340Phase 4Results posted
• A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 DiabetesCompletedNCT01624259Phase 3Results posted
• A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)CompletedNCT01621178Phase 3Results posted
• Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentCompletedNCT01620489Phase 3Results posted
• Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 DiabetesCompletedNCT01619059Phase 3Results posted
• Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 DiabetesCompletedNCT01618214Phase 4Results posted
• The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin TherapyCompletedNCT01618162Phase 3Results posted
• The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 DiabetesCompletedNCT01617434Phase 3Results posted
• Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)CompletedNCT01614769Phase 1Results posted
• Humalog® Mix50/50(tm) as a Treatment for Gestational DiabetesCompletedNCT01613807Phase 4Results posted
• Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseTerminatedNCT01609582Phase 3Results posted
• The Efficacy and Safety Study in Patients With Type 2 Diabetes MellitusCompletedNCT01608724Phase 4Results posted
• Modulation of Human Myocardial Metabolism by GLP-1 Dose ResponseCompletedNCT01607450Phase 2/3Results posted
• Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 DiabetesCompletedNCT01606007Phase 3Results posted
• Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by AmlodipineCompletedNCT01603940Phase 4Results posted
• Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes MellitusTerminatedNCT01603121Phase 1/2Results posted

← Diabetes Mellitus overview